CCL4 and colorectal carcinoma: In accordance with the previously described beneficial role of the CCR5 ligand CCL4 in the immunological control of colonic tumorigenesis, CRC tumors with intermediate to strong CCR5 expression seemed to have a better prognosis, indicated by Union International Contre Cancer (UICC) staging and less frequent lymph node involvement [33].